Leeward Investments LLC MA Sells 18,430 Shares of Humana Inc. (NYSE:HUM)

Leeward Investments LLC MA lowered its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 52.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 16,885 shares of the insurance provider's stock after selling 18,430 shares during the period. Leeward Investments LLC MA's holdings in Humana were worth $4,284,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV lifted its position in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after buying an additional 61 shares during the last quarter. FPC Investment Advisory Inc. bought a new stake in Humana in the 4th quarter valued at $27,000. Centricity Wealth Management LLC acquired a new stake in Humana during the 4th quarter valued at $30,000. Ashton Thomas Securities LLC bought a new position in Humana during the third quarter worth $31,000. Finally, Your Advocates Ltd. LLP increased its holdings in shares of Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm's stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.32% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on HUM. Barclays raised their target price on shares of Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a research note on Thursday, February 13th. JPMorgan Chase & Co. cut their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. TD Cowen upped their target price on Humana from $261.00 to $268.00 and gave the company a "hold" rating in a research report on Monday, November 4th. Morgan Stanley dropped their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. Finally, Bank of America raised Humana from an "underperform" rating to a "neutral" rating and upped their price objective for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $285.68.

Humana Stock Down 5.7 %

Shares of HUM opened at $255.77 on Monday. The firm has a 50 day simple moving average of $269.41 and a two-hundred day simple moving average of $289.61. The company has a market cap of $30.80 billion, a P/E ratio of 25.71, a P/E/G ratio of 2.05 and a beta of 0.56. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.38%. Humana's payout ratio is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.